Steen Stender

Author PubWeight™ 70.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010 5.86
2 Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010 5.46
3 Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010 4.38
4 Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatol 2013 2.18
5 Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006 2.12
6 Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr 2008 1.97
7 Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes Rev 2008 1.80
8 High levels of industrially produced trans fat in popular fast foods. N Engl J Med 2006 1.74
9 The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 2011 1.66
10 Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J 2005 1.50
11 Effect of sucrose on inflammatory markers in overweight humans. Am J Clin Nutr 2005 1.48
12 Effect of trans-fatty acid intake on insulin sensitivity and intramuscular lipids--a randomized trial in overweight postmenopausal women. Metabolism 2011 1.47
13 Long-term effects on haemostatic variables of three ad libitum diets differing in type and amount of fat and carbohydrate: a 6-month randomised study in obese individuals. Br J Nutr 2010 1.38
14 Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J 2004 1.24
15 Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. Am Heart J 2004 1.12
16 Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J 2002 1.11
17 [N-3 polyunsaturated acids and cardiovascular disease. Cochrane analysis with unclear conclusions]. Ugeskr Laeger 2005 1.09
18 Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 2004 1.02
19 Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr 2008 1.02
20 Haemostatic reference intervals in pregnancy. Thromb Haemost 2010 1.00
21 Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. J Allergy Clin Immunol 2012 1.00
22 Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med 2010 0.99
23 Health effect of the New Nordic Diet in adults with increased waist circumference: a 6-mo randomized controlled trial. Am J Clin Nutr 2013 0.98
24 Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS One 2013 0.95
25 Reduced endothelial nitric oxide synthase activity and concentration in fetal umbilical veins from maternal cigarette smokers. Am J Obstet Gynecol 2004 0.91
26 Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol 2005 0.91
27 Smoking cessation early in pregnancy and birth weight, length, head circumference, and endothelial nitric oxide synthase activity in umbilical and chorionic vessels: an observational study of healthy singleton pregnancies. Circulation 2009 0.91
28 Interaction between filaggrin null mutations and tobacco smoking in relation to asthma. J Allergy Clin Immunol 2011 0.91
29 What went in when trans went out? N Engl J Med 2009 0.90
30 Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients. Br J Clin Pharmacol 2011 0.90
31 Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res 2011 0.89
32 Higher protein diets consumed ad libitum improve cardiovascular risk markers in children of overweight parents from eight European countries. J Nutr 2013 0.88
33 A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open 2011 0.86
34 A novel multiplex analysis of filaggrin polymorphisms: a universally applicable method for genotyping. Clin Chim Acta 2012 0.86
35 Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis 2010 0.86
36 Treatment of chronic low back pain: a randomized, clinical trial comparing group-based multidisciplinary biopsychosocial rehabilitation and intensive individual therapist-assisted back muscle strengthening exercises. Spine (Phila Pa 1976) 2010 0.85
37 Nickel reactivity and filaggrin null mutations--evaluation of the filaggrin bypass theory in a general population. Contact Dermatitis 2011 0.84
38 [Dietary Recommendations 2005]. Ugeskr Laeger 2005 0.84
39 Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2007 0.83
40 Associations of filaggrin gene loss-of-function variants with urinary phthalate metabolites and testicular function in young Danish Men. Environ Health Perspect 2014 0.83
41 Trans, and n-3 polyunsaturated fatty acids and vascular function-a yin yang situation? Atheroscler Suppl 2006 0.83
42 Comparison of immunoglobulin E measurements on IMMULITE and ImmunoCAP in samples consisting of allergen-specific mouse-human chimeric monoclonal antibodies towards allergen extracts and four recombinant allergens. Int Arch Allergy Immunol 2013 0.81
43 Effect of protein and methionine intakes on plasma homocysteine concentrations: a 6-mo randomized controlled trial in overweight subjects. Am J Clin Nutr 2002 0.80
44 [Plasma lipids in non-fasting patients and signal values of laboratory results]. Ugeskr Laeger 2009 0.80
45 Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis. Contact Dermatitis 2013 0.80
46 Cancer antigen 125 after delivery in women with a normal pregnancy: a prospective cohort study. Acta Obstet Gynecol Scand 2014 0.79
47 Effects of different protein content and glycaemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomized, dietary intervention trial. Diabetes Metab Res Rev 2011 0.79
48 Association between loss-of-function mutations in the filaggrin gene and self-reported food allergy and alcohol sensitivity. Int Arch Allergy Immunol 2013 0.79
49 Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Derm Venereol 2014 0.78
50 Filaggrin compound heterozygous patients carry mutations in trans position. Exp Dermatol 2013 0.78
51 Filaggrin null-mutations may be associated with a distinct subtype of atopic hand eczema. Acta Derm Venereol 2010 0.78
52 Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients. Diabetes Care 2002 0.77
53 Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers. Eur Heart J Cardiovasc Imaging 2013 0.77
54 n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial. Lipids 2014 0.76
55 Maternal smoking and impaired endothelium-dependent nitric oxide-mediated relaxation of uterine small arteries in vitro. Am J Obstet Gynecol 2010 0.76
56 Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial. Pharmacogenet Genomics 2012 0.76
57 Effects on markers of inflammation and endothelial cell function of three ad libitum diets differing in type and amount of fat and carbohydrate: a 6-month randomised study in obese individuals. Br J Nutr 2011 0.76
58 [Effect of fats on cardiovascular disease prevention in Denmark]. Ugeskr Laeger 2014 0.75
59 Low variation and high reproducibility in plaque volume with intravascular ultrasound. Int J Cardiol 2004 0.75
60 [The impact of sugar on health]. Ugeskr Laeger 2003 0.75
61 [Trans fats--good if Sweden could follow the Danish example]. Lakartidningen 2007 0.75
62 Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthood. Contact Dermatitis 2013 0.75
63 Poor performance of mandatory nutritional screening of in-hospital patients. Clin Nutr 2012 0.75
64 [Cholesterol--when is preventive treatment with statin indicated?]. Ugeskr Laeger 2011 0.75
65 [Smoking cessation during pregnancy, newborn size, and NO-synthase activity in endothelial cells of the umbilical cord--secondary publication]. Ugeskr Laeger 2009 0.75
66 [Hormone replacement therapy and ischemic heart disease--a dangerous cocktail? Changes in the collected evidence]. Ugeskr Laeger 2003 0.75
67 Filaggrin haploinsufficiency among patients with dermatitis from a tertiary referral centre: early findings and possible phenotype. Contact Dermatitis 2010 0.75